StockComparison Logo
vs

DNA vs PRME

Comparison between Ginkgo Bioworks Holdings Inc - Class A (DNA, Company) and Prime Medicine Inc (PRME, Company).

Both DNA and PRME are from the Healthcare sector.

DNA vs PRME - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
DNA
$490M
PRME
$489M
Max Drawdown
DNA
99.10%
Winner
PRME
94.55%
Sharpe Ratio
DNA
0.40
Winner
PRME
1.05
5Y Beta
DNA
2.38
Winner
PRME
2.13
Industry
DNA
Biotechnology
PRME
Biotechnology
P/E Ratio
DNA
-1.52
Winner
PRME
-2.26
Debt to Equity
DNA
0.00%
PRME
0.00%
Free Cash Flow Yield
DNA
-34.36%
Winner
PRME
-32.43%
P/S Ratio
Winner
DNA
3.32
PRME
121.34
P/B Ratio
Winner
DNA
1.17
PRME
6.38

DNA vs PRME - Historical Returns

Returns include dividend reinvestment.

1M
Winner
DNA
-5.34%
PRME
-15.91%
3M
Winner
DNA
+23.36%
PRME
-25.60%
6M
Winner
DNA
-15.47%
PRME
-32.32%
1Y
DNA
-15.02%
Winner
PRME
+90.07%
5Y(CAGR)
DNA
-54.38%
PRME
N/A
Max(CAGR)
DNA
-53.46%
Winner
PRME
-37.48%

DNA vs PRME - Annual Returns (2021 - 2026)

Returns include dividend reinvestment.

YearDNAPRME
2026-9.25%-21.39%
2025-18.69%+16.05%
2024-85.30%-66.67%
2023+6.96%-49.49%
2022-80.55%+20.88%
2021-17.89%N/A

DNA vs PRME Drawdown Comparison

The maximum drawdown for DNA was -99.10%, occurring on Sep 9, 2024. This drawdown has not yet recovered.

The maximum drawdown for PRME was -94.55%, occurring on Apr 8, 2025. This drawdown has not yet recovered.

The current DNA drawdown is -98.68%. The current PRME drawdown is -86.86%.

RankDNAPRME
#1-99.10%
Nov 8, 2021 - Sep 9, 2024
-94.55%
Nov 1, 2022 - Apr 8, 2025
#2-28.69%
Sep 27, 2021 - Oct 19, 2021
-3.55%
Oct 21, 2022 - Oct 25, 2022
#3-11.76%
Apr 23, 2021 - Sep 16, 2021
N/A
#4-11.28%
Oct 19, 2021 - Nov 8, 2021
N/A
#5-8.78%
Sep 17, 2021 - Sep 23, 2021
N/A

Correlation

Correlation between DNA and PRME is 0.90 which considered as a strong positive correlation - the stocks tend to move together.

0.90
-101

Select Stocks to Compare